首页|期刊导航|中华医学杂志(英文版)|Comparison of blinatumomab and chimeric antigen receptor T cells pre-haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome negative B-cell acute lymphoblastic leukemia
Comparison of blinatumomab and chimeric antigen receptor T cells pre-haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome negative B-cell acute lymphoblastic leukemia
Guanhua Hu Pan Suo Lu Bai Xiaohui Zhang Yifei Cheng Xiaojun Huang
中华医学杂志(英文版)2025,Vol.138Issue(4):472-474,3.
中华医学杂志(英文版)2025,Vol.138Issue(4):472-474,3.DOI:10.1097/CM9.0000000000003396
Comparison of blinatumomab and chimeric antigen receptor T cells pre-haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome negative B-cell acute lymphoblastic leukemia
Comparison of blinatumomab and chimeric antigen receptor T cells pre-haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome negative B-cell acute lymphoblastic leukemia
摘要
引用本文复制引用
Guanhua Hu,Pan Suo,Lu Bai,Xiaohui Zhang,Yifei Cheng,Xiaojun Huang..Comparison of blinatumomab and chimeric antigen receptor T cells pre-haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome negative B-cell acute lymphoblastic leukemia[J].中华医学杂志(英文版),2025,138(4):472-474,3.基金项目
This work was supported by grants from the project(No.RDJP2022-71),Peking University People's Hospital Scientific Research Development Funds and the CAMS Innovation Fund for Medical Sciences(CIFMS)(No.2019-12M-5-034). (No.RDJP2022-71)